| |
| |
|
| Insider
Information: |
Currie Mark G |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
795,756 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,475,995 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
795,756 |
|
|
| Total
Value |
$3,475,995 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 189.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ironwood Pharmaceuticals Inc |
IRWD |
Director |
2023-06-20 |
544,108 |
|
0 |
Premium* |
|
|
Cyclerion Therapeutics, Inc. |
CYCN |
|
2020-12-28 |
251,648 |
2019-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-08-22 |
4 |
OE |
$4.89 |
$321,784 |
D/D |
65,000 |
840,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-08-23 |
4 |
OE |
$4.89 |
$321,784 |
D/D |
65,000 |
840,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-08-24 |
4 |
OE |
$4.89 |
$321,783 |
D/D |
65,000 |
840,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2017-03-14 |
4 |
OE |
$3.76 |
$225,600 |
D/D |
60,000 |
835,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-01-24 |
4 |
OE |
$3.76 |
$225,600 |
D/D |
60,000 |
835,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
775,000 |
805,124 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2019-02-20 |
4 |
AS |
$14.31 |
$23,340 |
D/D |
(1,631) |
803,493 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2019-02-21 |
4 |
AS |
$14.32 |
$186 |
D/D |
(13) |
803,480 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2017-01-18 |
4 |
OE |
$2.94 |
$164,602 |
D/D |
55,987 |
775,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2017-03-14 |
4 |
S |
$17.06 |
$1,023,600 |
D/D |
(60,000) |
775,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-01-24 |
4 |
AS |
$15.45 |
$927,000 |
D/D |
(60,000) |
775,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-08-22 |
4 |
AS |
$18.51 |
$1,203,150 |
D/D |
(65,000) |
775,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-08-23 |
4 |
AS |
$18.39 |
$1,195,350 |
D/D |
(65,000) |
775,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-08-24 |
4 |
AS |
$18.39 |
$1,195,350 |
D/D |
(65,000) |
775,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2017-01-06 |
4 |
OE |
$2.94 |
$99,998 |
D/D |
34,013 |
719,013 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2016-10-31 |
4 |
OE |
$2.94 |
$882,000 |
D/D |
300,000 |
685,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Director |
– • – |
2020-01-23 |
4 |
OE |
$9.12 |
$547,200 |
D/D |
60,000 |
609,272 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
22,766 |
593,758 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Director |
– • – |
2022-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
21,571 |
591,758 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2019-03-07 |
4 |
S |
$13.29 |
$2,996,895 |
D/D |
(225,500) |
577,980 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Director |
– • – |
2020-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
21,720 |
570,992 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Director |
– • – |
2019-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
22,706 |
551,609 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Director |
– • – |
2019-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,837 |
549,772 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Director |
– • – |
2019-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
549,272 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Director |
– • – |
2020-01-23 |
4 |
AS |
$12.59 |
$755,400 |
D/D |
(60,000) |
549,272 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
